Evidence map›Paper›PMID 33260564›Full record

ReviewInternational journal of molecular sciences2020

The Pathophysiological Role of CoA.

Aleksandra Czumaj, Sylwia Szrok-Jurga, Areta Hebanowska, Jacek Turyn, Julian Swierczynski, Tomasz Sledzinski, Ewa Stelmanska

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Pantothenic Acid Derivatives Modulate Oxidative Stress and Hepatic Fibrosis in Bile Duct Ligation-Induced Cholestatic Liver Injury.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aleksandra CzumajDepartment of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk, 80-211 Gdańsk, Poland.ORCID 0000-0002-3072-6334
Sylwia Szrok-JurgaDepartment of Biochemistry, Faculty of Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland.ORCID 0000-0002-2667-7242
Areta HebanowskaDepartment of Biochemistry, Faculty of Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland.ORCID 0000-0002-0218-4590
Jacek TurynDepartment of Biochemistry, Faculty of Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland.ORCID 0000-0003-4909-0214
Julian SwierczynskiState School of Higher Vocational Education in Koszalin, 75-582 Koszalin, Poland.
Tomasz SledzinskiDepartment of Pharmaceutical Biochemistry, Faculty of Pharmacy, Medical University of Gdansk, 80-211 Gdańsk, Poland.ORCID 0000-0002-9028-3790
Ewa StelmanskaDepartment of Biochemistry, Faculty of Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland.ORCID 0000-0001-8222-8575
Gdańsk Medical University · PLState Higher Vocational School in Koszalin · PL

Funding

Medical University of Gdansk ST40 and ST41Narodowe Centrum Nauki 2016/22/E/NZ4/00665
6 · The paper itself

Abstract

The importance of coenzyme A (CoA) as a carrier of acyl residues in cell metabolism is well understood. Coenzyme A participates in more than 100 different catabolic and anabolic reactions, including those involved in the metabolism of lipids, carbohydrates, proteins, ethanol, bile acids, and xenobiotics. However, much less is known about the importance of the concentration of this cofactor in various cell compartments and the role of altered CoA concentration in various pathologies. Despite continuous research on these issues, the molecular mechanisms in the regulation of the intracellular level of CoA under pathological conditions are still not well understood. This review summarizes the current knowledge of (a) CoA subcellular concentrations; (b) the roles of CoA synthesis and degradation processes; and (c) protein modification by reversible CoA binding to proteins (CoAlation). Particular attention is paid to (a) the roles of changes in the level of CoA under pathological conditions, such as in neurodegenerative diseases, cancer, myopathies, and infectious diseases; and (b) the beneficial effect of CoA and pantethine (which like CoA is finally converted to Pan and cysteamine), used at pharmacological doses for the treatment of hyperlipidemia.

Indexed as

AnimalsBiosynthetic PathwaysCoenzyme AHumansMammalsPolymorphism, Single NucleotideProtein Processing, Post-TranslationalSubstrate SpecificityCoenzyme AcancerCoACoAlationcoenzyme Aneurodegenerative diseases

Identifiers

PMID33260564
PMCPMC7731229
OpenAlexW3107116806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.